Targeted anti-vascular therapies for ovarian cancer: Current evidence

Hall, M, Gourley, C, Mcneish, I et al. (6 more authors) (2013) Targeted anti-vascular therapies for ovarian cancer: Current evidence. British Journal of Cancer, 108 (2). pp. 250-258. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2013 Cancer Research UK. This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: ovary cancer; VEGF inhibitors; anti-angiogenesis; tyrosine kinase inhibitors; vascular disruptive agents; metronomic chemotherapy
Dates:
  • Published: 5 February 2013
  • Accepted: 2 November 2012
  • Published (online): 5 February 2013
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 22 Aug 2016 13:51
Last Modified: 22 Aug 2016 13:51
Published Version: http://dx.doi.org/10.1038/bjc.2012.541
Status: Published
Publisher: Cancer Research UK
Identification Number: https://doi.org/10.1038/bjc.2012.541
Related URLs:

Share / Export

Statistics